Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852640 · ClinicalTrials.gov registry record · NA
Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04852640: Completed NA study, sponsored by University of Minnesota.
NCT04852640 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04852640, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the proposed work is to screen the effectiveness of an evidence-based, targeted, treatment intervention versus a non-specific, generalized, treatment intervention to treat symptomatic shoulder instability in collegiate swimmers. The results of the study will allow direct observation of treatment effects designed to mitigate the effects of symptomatic shoulder instability. These results will facilitate the optimization of future treatments and interventions.
Primary Outcome
The magnitude of humeral head translations will be measured as the distance traveled by the humeral head relative to the scapular glenoid. The units of measure for this variable is distance, recorded in millimeters (mm). These measurements will be recorded with biplane radiographic motion analysis.
Interventions
- PROCEDURE Active Rehabilitation Program (ARP)
- PROCEDURE Nonspecific Passive Intervention (NPI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2023-01-04 |
| Phase | NA |
What the finished NCT04852640 record still lists
NCT04852640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Active Rehabilitation Program (ARP) is the first listed.
NCT04852640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04852640 about?
NCT04852640 is a clinical study titled "Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial". The purpose of the proposed work is to screen the effectiveness of an evidence-based, targeted, treatment intervention versus a non-specific, generalized, treatment intervention to treat symptomatic shoulder instability in collegiate swimmers. The results of the study will allow direct observation o...
What is the current status of trial NCT04852640?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-09-01. Estimated completion is 2023-01-04.
What interventions are being tested in trial NCT04852640?
The interventions under investigation include: Active Rehabilitation Program (ARP) (PROCEDURE), Nonspecific Passive Intervention (NPI) (PROCEDURE).
Who is sponsoring clinical trial NCT04852640?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04852640's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI